【24h】

Lipid Nanoparticles: Tumor-targeting Nanocargos for Drug and Contrast Agent Delivery

机译:脂质纳米颗粒:用于药物和造影剂输送的靶向肿瘤的纳米货物。

获取原文

摘要

A new technology for the encapsulation of lipophilic molecules -both drugs and contrast agents- has been developed, based on oil-in-water nanoemulsions. Physico-chemical characterizations of the nanoparticles evidence highly stable lipid nanoemulsions with amorphous core of temperature- and composition- tunable viscosity. Particles display low in vitro cytotoxicity (IC50 > 300 μg/mL of lipids), and high tolerance in vivo. They can be efficiently loaded with hydrophobic to amphiphilic molecules, such as fluorescent dyes for tumor labeling, photosensitizers for phototherapy, or chemotoxic drugs. The presence of PEGylated surfactants in the particle coating ensures a good in vivo stealthiness, as assessed by their biodistribution recorded using fluorescence imaging and radioactivity counting (~(14)C and ~3H particle labeling). The lipid nanoparticles can moreover be functionalized by tumor-targeting ligands, such as the cRGD peptide, to improve specific tumor cell accumulation.
机译:基于水包油纳米乳剂,已经开发了一种用于包封亲脂性分子的新技术(包括药物和造影剂)。纳米颗粒的理化特性表明,脂质纳米乳液具有高度稳定的稳定性,其非晶核的温度和组成均可调。颗粒在体外具有较低的细胞毒性(IC50> 300μg/ mL脂质),在体内具有较高的耐受性。它们可以有效地负载疏水性至两亲性分子,例如用于肿瘤标记的荧光染料,用于光疗的光敏剂或化学毒性药物。通过使用荧光成像和放射性计数(〜(14)C和〜3H粒子标记)记录的生物分布来评估,粒子涂层中PEG化表面活性剂的存在确保了良好的体内隐身性。此外,脂质纳米颗粒可以被靶向肿瘤的配体例如cRGD肽功能化,以改善特异性肿瘤细胞的积累。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号